For pharmaceutical R&D scientists and procurement managers, the efficient and reliable sourcing of critical chemical intermediates is a cornerstone of successful drug development and manufacturing. Cis-2-(Bromomethyl)-2-(2,4-Dichlorophenyl)-1,3-Dioxolane-4-Ylmethyl Benzoate, identified by its CAS number 61397-56-6, is a compound of particular interest due to its indispensable role in the synthesis of essential antifungal medications. This guide provides practical advice on how to approach the procurement of this vital intermediate.
Identifying Your Needs: Purity and Specifications
Before embarking on the procurement journey, it is crucial to clearly define your requirements. For Cis-2-(Bromomethyl)-2-(2,4-Dichlorophenyl)-1,3-Dioxolane-4-Ylmethyl Benzoate, the primary concern is purity, with a minimum of 98% often being the benchmark for pharmaceutical synthesis. Beyond purity, consider other specifications such as the desired physical form (typically a white powder), particle size if relevant, and any specific impurity limits that may be dictated by your downstream synthesis or regulatory filings. Understanding these details will allow you to effectively communicate your needs to potential suppliers and filter out unsuitable options.
The Advantage of Direct Sourcing from Manufacturers
While distributors play a role in the chemical supply chain, direct sourcing from manufacturers often provides distinct advantages. Manufacturers of CAS 61397-56-6, particularly those based in established chemical production hubs like China, can typically offer more competitive pricing for bulk quantities. Furthermore, direct engagement allows for more transparent communication regarding production processes, quality control measures, and lead times. This direct relationship is invaluable for building a robust and reliable supply chain. When you buy directly, you can often inquire about obtaining free samples to conduct your own quality assessments before committing to a large purchase.
Key Factors in Selecting a Supplier
Choosing the right supplier for Cis-2-(Bromomethyl)-2-(2,4-Dichlorophenyl)-1,3-Dioxolane-4-Ylmethyl Benzoate is critical. Consider the following:
When comparing potential suppliers, always request a detailed quote that includes all relevant costs, shipping, and expected delivery timelines. Do not hesitate to ask for technical support or clarification on any aspect of the product or its supply.
Conclusion: Securing Your Supply Chain
The consistent availability of high-quality Cis-2-(Bromomethyl)-2-(2,4-Dichlorophenyl)-1,3-Dioxolane-4-Ylmethyl Benzoate is essential for the uninterrupted production of vital antifungal drugs. By approaching procurement with a clear understanding of your needs, prioritizing direct sourcing from reputable manufacturers, and carefully vetting potential suppliers, you can secure a stable and cost-effective supply chain. For those seeking to purchase this intermediate, exploring experienced manufacturers in China offers a strategic advantage. Engage with a trusted supplier today to ensure you have the quality pharmaceutical intermediates necessary for your operations.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.